Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2012; 18(24): 3112-3118
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3112
Table 1 Statistical analysis of riboflavin transporter 2 expression and clinicopathologic factors in gastric cancer n (%)
CharacteristicsnRFT2 expression
ZP value
++++++
Normal mucous epithelia606 (10.0)10 (16.7)16 (26.7)28 (46.7)-7.937< 0.001
Gastric cancer6045 (75.0)10 (16.7)5 (8.3)0
Gender
Male3931 (79.5)6 (15.4)3 (7.7)0-0.6210.534
Female2114 (66.7)4 (19.0)2 (9.5)0
Ethnic groups
Han3221 (55.0)8 (25.0)3 (20.0)0-1.9430.052
Uyghur2824 (81.82)2 (13.6)2 (4.5)0
Tumor location
Cardia of stomach102 (20.0)4 (40.0)4 (40.0)0-3.1270.209
Body of stomach118 (72.1)2 (18.2)1 (8.7)0
Antrum of stomach3935 (89.7)4 (10.3)00
Differentiation
Moderate/well1910 (52.6)5 (26.3)4 (21.1)0-2.8340.005
Poor4135 (85.4)5 (12.2)1 (2.3)0
L/N metastasis
Negative109 (90.0)1 (10.0)00-1.2450.28
Positive5036 (72.0)9 (18.0)5 (10.0)
Stage
II and IIIa4127 (65.9)9 (22.0)5 (12.1)0-2.4140.019
IIIb and IV1918 (94.7)1 (5.3)00
Table 2 Statistical analysis of riboflavin transporter 2 expression and blood riboflavin levels in gastric cancer (mean ± SD)
RFT2 protein expressionRiboflavin levelχ2P value
0.7012 ± 0.68 778-2.6190.019
+1.6425 ± 1.01 783
++2.9691 ± 1.30 345